SLC39A10

gene
On this page

Also known as KIAA1265FLJ90515DKFZp564L2123ZIP10

Summary

SLC39A10 (solute carrier family 39 member 10, HGNC:20861) is a protein-coding gene on chromosome 2q32.3, encoding Zinc transporter ZIP10 (Q9ULF5). Zinc-influx transporter. It is a selective cancer dependency (DepMap: 31.2% of cell lines).

Zinc is an essential cofactor for hundreds of enzymes. It is involved in protein, nucleic acid, carbohydrate, and lipid metabolism, as well as in the control of gene transcription, growth, development, and differentiation. SLC39A10 belongs to a subfamily of proteins that show structural characteristics of zinc transporters (Taylor and Nicholson, 2003 [PubMed 12659941]).

Source: NCBI Gene 57181 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 97 total
  • Cancer dependency (DepMap): dependent in 31.2% of screened cell lines
  • MANE Select transcript: NM_020342

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:20861
Approved symbolSLC39A10
Namesolute carrier family 39 member 10
Location2q32.3
Locus typegene with protein product
StatusApproved
AliasesKIAA1265, FLJ90515, DKFZp564L2123, ZIP10
Ensembl geneENSG00000196950
Ensembl biotypeprotein_coding
OMIM608733
Entrez57181

Gene structure

Transcript identifiers

Ensembl transcripts: 47 — 43 protein_coding, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000359634, ENST00000409086, ENST00000412905, ENST00000418005, ENST00000430412, ENST00000444421, ENST00000458054, ENST00000464301, ENST00000465851, ENST00000867303, ENST00000867304, ENST00000867305, ENST00000867306, ENST00000867307, ENST00000867308, ENST00000919571, ENST00000919572, ENST00000919573, ENST00000919574, ENST00000919575, ENST00000919576, ENST00000919577, ENST00000919578, ENST00000919579, ENST00000919580, ENST00000919581, ENST00000919582, ENST00000919583, ENST00000919584, ENST00000919585, ENST00000919586, ENST00000919587, ENST00000919588, ENST00000919589, ENST00000919590, ENST00000919591, ENST00000919592, ENST00000919593, ENST00000919594, ENST00000919595, ENST00000919596, ENST00000919597, ENST00000919598, ENST00000919599, ENST00000956076, ENST00000956077, ENST00000956078

RefSeq mRNA: 2 — MANE Select: NM_020342 NM_001127257, NM_020342

CCDS: CCDS33353

Canonical transcript exons

ENST00000359634 — 10 exons

ExonStartEnd
ENSE00001400249195680032195681050
ENSE00003556626195718252195718332
ENSE00003560348195706616195706785
ENSE00003560904195708656195708844
ENSE00003603452195683699195683906
ENSE00003645146195728159195728349
ENSE00003665054195713433195713553
ENSE00003671434195716637195717005
ENSE00003848195195734883195737700
ENSE00003850270195657226195657281

Expression profiles

Bgee: expression breadth ubiquitous, 248 present calls, max score 98.32.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 39.7450 / max 1377.9470, expressed in 1800 samples.

FANTOM5 promoters (13 alternative TSS)

Promoter IDTPM avgSamples expressed
2442426.13221745
244256.98311607
244222.4409982
244231.5920758
244200.6948298
244210.4153188
244330.3058130
244190.2723125
244280.261587
244340.230495

Top tissues by expression

253 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
middle temporal gyrusUBERON:000277198.32gold quality
secondary oocyteCL:000065598.06gold quality
Brodmann (1909) area 46UBERON:000648397.29gold quality
superior frontal gyrusUBERON:000266196.76gold quality
oocyteCL:000002396.55gold quality
Brodmann (1909) area 23UBERON:001355496.15gold quality
adrenal tissueUBERON:001830395.57gold quality
germinal epithelium of ovaryUBERON:000130495.49gold quality
postcentral gyrusUBERON:000258195.38gold quality
right lobe of thyroid glandUBERON:000111995.15gold quality
parietal lobeUBERON:000187294.91gold quality
dorsolateral prefrontal cortexUBERON:000983494.49gold quality
Brodmann (1909) area 9UBERON:001354094.45gold quality
left lobe of thyroid glandUBERON:000112094.41gold quality
prefrontal cortexUBERON:000045194.16gold quality
thyroid glandUBERON:000204694.13gold quality
ventricular zoneUBERON:000305393.93gold quality
frontal cortexUBERON:000187093.65gold quality
entorhinal cortexUBERON:000272893.54gold quality
ganglionic eminenceUBERON:000402393.28gold quality
neocortexUBERON:000195093.26gold quality
cerebral cortexUBERON:000095693.20gold quality
calcaneal tendonUBERON:000370193.09gold quality
primary visual cortexUBERON:000243692.93gold quality
occipital lobeUBERON:000202192.36gold quality
anterior cingulate cortexUBERON:000983591.91gold quality
parietal pleuraUBERON:000240091.56gold quality
stromal cell of endometriumCL:000225591.54gold quality
right uterine tubeUBERON:000130291.43gold quality
temporal lobeUBERON:000187191.40gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 2.

ExperimentMarker?Max mean expression
E-GEOD-137537yes6.41
E-ANND-3yes4.35

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): MTF1, ZNF20

miRNA regulators (miRDB)

238 targeting SLC39A10, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-5011-5P100.0083.465820
HSA-MIR-3646100.0073.565283
HSA-MIR-4692100.0067.322066
HSA-MIR-3163100.0077.238605
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-8485100.0077.574731
HSA-MIR-30B-5P100.0076.293248
HSA-MIR-30C-5P100.0076.293248
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-30A-5P100.0076.313233
HSA-MIR-30D-5P100.0076.323233
HSA-MIR-30E-5P100.0076.323242
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-366299.9973.825684
HSA-MIR-451499.9967.101870
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-513B-5P99.9969.962150
HSA-MIR-806899.9873.852376
HSA-MIR-499A-5P99.9870.791323
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-314899.9775.066478
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-3065-5P99.9771.563281
HSA-MIR-426799.9666.532368
HSA-MIR-570-3P99.9672.414910
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-4666A-3P99.9671.713434

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 31.2% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 10)

  • Zinc and its transporters, ZIP6 and ZIP10, are required for the breast cancer cells motility stimulated with high glucose level, such as in diabetes. (PMID:24587242)
  • A significant correlation between ZIP10 mRNA expressions with aggressiveness of RCC. (PMID:25200496)
  • Slc39a10 plays a role in promoting the survival of macrophages through a Zn/p53-dependent axis in response to inflammatory stimuli. (PMID:29180421)
  • ZIP10 is found in the proximal tubules collecting duct system and has a role in renal zinc transport. (PMID:30520657)
  • Possible involvement of zinc transporter ZIP10 in atopic dermatitis. (PMID:31875492)
  • The ZIP6/ZIP10 heteromer is essential for the zinc-mediated trigger of mitosis. (PMID:32797246)
  • ZIP10 drives osteosarcoma proliferation and chemoresistance through ITGA10-mediated activation of the PI3K/AKT pathway. (PMID:34706747)
  • The bZIP transcription factor BATF3/ZIP-10 suppresses innate immunity by attenuating PMK-1/p38 signaling. (PMID:36409527)
  • Functional characterization of SLC39 family members ZIP5 and ZIP10 in overexpressing HEK293 cells reveals selective copper transport activity. (PMID:36454509)
  • SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the CK2-mediated MAPK/ERK and PI3K/AKT pathways. (PMID:37524874)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_rerioslc39a10ENSDARG00000005823
mus_musculusSlc39a10ENSMUSG00000025986
rattus_norvegicusSlc39a10ENSRNOG00000011677
drosophila_melanogasterfoiFBGN0024236

Paralogs (6): SLC39A14 (ENSG00000104635), SLC39A8 (ENSG00000138821), SLC39A5 (ENSG00000139540), SLC39A6 (ENSG00000141424), SLC39A4 (ENSG00000147804), SLC39A12 (ENSG00000148482)

Protein

Protein identifiers

Zinc transporter ZIP10Q9ULF5 (reviewed: Q9ULF5)

Alternative names: Solute carrier family 39 member 10, Zrt- and Irt-like protein 10

All UniProt accessions (5): C9J0F5, E7ENT5, E7EV45, F2Z341, Q9ULF5

UniProt curated annotations — full annotation on UniProt →

Function. Zinc-influx transporter. When associated with SLC39A6, the heterodimer formed by SLC39A10 and SLC39A6 mediates cellular zinc uptake to trigger cells to undergo epithelial-to-mesenchymal transition (EMT). SLC39A10-SLC39A6 heterodimers play also an essentiel role in initiating mitosis by importing zinc into cells to initiate a pathway resulting in the onset of mitosis. Plays an important for both mature B-cell maintenance and humoral immune responses. When associated with SLC39A10, the heterodimer controls NCAM1 phosphorylation and integration into focal adhesion complexes during EMT.

Subunit / interactions. Interacts with SLC39A6; which triggers cells to undergo EMT and mitosis. Found in a complex with SLC39A6, SLC39A10 and with the ‘Ser-727’ phosphorylated form of STAT3 throughout mitosis. Found in a complex with SLC39A6, SLC39A10 and with NCAM1; this complex controls NCAM1 phosphorylation and integration into focal adhesion complexes during epithelial-tomesenchymal transition. Found in a complex with SLC39A6, SLC39A10 and with GSK3B that controls NCAM1 phosphorylation.

Subcellular location. Cell membrane. Apical cell membrane.

Post-translational modifications. Undergoes N-terminal ectodomain shedding.

Induction. Up-regulated in several breast cancer lines, and correlated to cancer progression as a marker of metastatic breast cancer.

Similarity. Belongs to the ZIP transporter (TC 2.A.5) family.

Isoforms (2)

UniProt IDNamesCanonical?
Q9ULF5-11yes
Q9ULF5-22

RefSeq proteins (2): NP_001120729, NP_065075* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003689ZIPFamily
IPR050799ZIP_TransporterFamily

Pfam: PF02535

Catalyzed reactions (Rhea), 1 shown:

  • Zn(2+)(in) = Zn(2+)(out) (RHEA:29351)

UniProt features (29 total): compositionally biased region 8, transmembrane region 7, glycosylation site 4, modified residue 3, region of interest 2, signal peptide 1, chain 1, splice variant 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9ULF5-F158.430.08

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (3): 536, 553, 591

Glycosylation sites (4): 139, 198, 218, 339

Function

Pathways and Gene Ontology

Reactome pathways

6 pathways

IDPathway
R-HSA-442380Zinc influx into cells by the SLC39 gene family
R-HSA-382551Transport of small molecules
R-HSA-425366
R-HSA-425407SLC-mediated transmembrane transport
R-HSA-425410Metal ion SLC transporters
R-HSA-435354Zinc transporters

MSigDB gene sets: 270 (showing top): GSE45365_NK_CELL_VS_BCELL_UP, WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN, GOBP_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY, GOBP_REGULATION_OF_CELL_ACTIVATION, GOBP_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY, GOBP_REGULATION_OF_LEUKOCYTE_PROLIFERATION, GGTGTGT_MIR329, MODULE_169, GOBP_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS, GOBP_B_CELL_ACTIVATION, GOBP_TRANSITION_METAL_ION_TRANSPORT, GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY, GOBP_B_CELL_PROLIFERATION, GOBP_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS, ATGCAGT_MIR217

GO Biological Process (13): epithelial to mesenchymal transition (GO:0001837), negative regulation of B cell apoptotic process (GO:0002903), intracellular zinc ion homeostasis (GO:0006882), intracellular monoatomic cation homeostasis (GO:0030003), positive regulation of B cell proliferation (GO:0030890), positive regulation of B cell receptor signaling pathway (GO:0050861), zinc ion transmembrane transport (GO:0071577), zinc ion import across plasma membrane (GO:0071578), monoatomic ion transport (GO:0006811), zinc ion transport (GO:0006829), bicarbonate transport (GO:0015701), metal ion transport (GO:0030001), transmembrane transport (GO:0055085)

GO Molecular Function (5): zinc ion transmembrane transporter activity (GO:0005385), protein tyrosine phosphatase activator activity (GO:0008160), monoatomic cation:bicarbonate symporter activity (GO:0140410), protein binding (GO:0005515), metal ion transmembrane transporter activity (GO:0046873)

GO Cellular Component (3): plasma membrane (GO:0005886), apical plasma membrane (GO:0016324), membrane (GO:0016020)

Reactome top-level categories

Rollup of top-4 pathways:

CategoryPathways
Zinc transporters1
Transport of small molecules1
SLC-mediated transmembrane transport1
Metal ion SLC transporters1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transport3
zinc ion transmembrane transport2
mesenchymal cell differentiation1
B cell apoptotic process1
regulation of B cell apoptotic process1
negative regulation of lymphocyte apoptotic process1
intracellular monoatomic cation homeostasis1
inorganic ion homeostasis1
intracellular monoatomic ion homeostasis1
monoatomic cation homeostasis1
regulation of B cell proliferation1
B cell proliferation1
positive regulation of lymphocyte proliferation1
positive regulation of B cell activation1
B cell receptor signaling pathway1
regulation of B cell receptor signaling pathway1
positive regulation of antigen receptor-mediated signaling pathway1
zinc ion transport1
monoatomic cation transmembrane transport1
inorganic cation import across plasma membrane1
transition metal ion transport1
monoatomic cation transport1
cellular process1
transition metal ion transmembrane transporter activity1
protein tyrosine phosphatase activity1
protein phosphatase activator activity1
bicarbonate transmembrane transporter activity1
solute:monoatomic cation symporter activity1
binding1
monoatomic cation transmembrane transporter activity1
metal ion transport1
membrane1
cell periphery1
apical part of cell1
plasma membrane region1
cellular anatomical structure1

Protein interactions and networks

STRING

828 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
SLC39A10SLC39A9Q9NUM3808
SLC39A10SLC30A1Q9Y6M5804
SLC39A10SLC39A1Q9NY26794
SLC39A10SLC39A11Q8N1S5766
SLC39A10SLC30A5Q8TAD4753
SLC39A10SLC30A4O14863747
SLC39A10SLC30A2Q9BRI3733
SLC39A10SLC30A6Q6NXT4733
SLC39A10SLC30A7Q8NEW0731
SLC39A10SLC30A9Q6PML9714
SLC39A10SLC39A6Q13433684
SLC39A10SLC30A10Q6XR72670
SLC39A10SLC30A3Q99726640
SLC39A10SLC39A3Q9BRY0621
SLC39A10SLC39A2Q9NP94617

IntAct

113 interactions, top by confidence:

ABTypeScore
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
LRRC32SMPD2psi-mi:“MI:0914”(association)0.640
GPR156PLD2psi-mi:“MI:0914”(association)0.640
SLC39A5TMEM223psi-mi:“MI:0914”(association)0.530
LPAR1TMEM223psi-mi:“MI:0914”(association)0.530
GYPBTCAF2psi-mi:“MI:0914”(association)0.530
SPINT2UPK3BL1psi-mi:“MI:0914”(association)0.530
GALNT6NDUFS4psi-mi:“MI:0914”(association)0.530
HTR2CKLRG2psi-mi:“MI:0914”(association)0.530
LGALS1PODXLpsi-mi:“MI:0914”(association)0.530
LGALS1LAMA5psi-mi:“MI:0914”(association)0.530
NRASESYT2psi-mi:“MI:2364”(proximity)0.480
NRN1LSLC39A10psi-mi:“MI:0915”(physical association)0.400
Bmpr1aPLEKHG3psi-mi:“MI:0914”(association)0.350
Cdca8NAP1L1psi-mi:“MI:0914”(association)0.350
Smad3psi-mi:“MI:0914”(association)0.350
Cul1GPS1psi-mi:“MI:0914”(association)0.350
TnksSDC2psi-mi:“MI:0914”(association)0.350
NcaphATP5MF-PTCD1psi-mi:“MI:0914”(association)0.350
Aff1UVRAGpsi-mi:“MI:0914”(association)0.350
TCF20MTA3psi-mi:“MI:0914”(association)0.350
KIF18ANCOR1psi-mi:“MI:0914”(association)0.350
KIF7TBC1D31psi-mi:“MI:0914”(association)0.350
MYCTARS3psi-mi:“MI:0914”(association)0.350

BioGRID (285): SLC39A10 (Affinity Capture-MS), SLC39A10 (Affinity Capture-MS), SLC39A10 (Affinity Capture-MS), SLC39A10 (Proximity Label-MS), SLC39A10 (Proximity Label-MS), SLC39A10 (Proximity Label-MS), SLC39A10 (Affinity Capture-MS), SLC39A10 (Affinity Capture-MS), SLC39A10 (Affinity Capture-MS), SLC39A10 (Affinity Capture-MS), SLC39A10 (Affinity Capture-MS), SLC39A10 (Affinity Capture-MS), SLC39A10 (Affinity Capture-MS), SLC39A10 (Affinity Capture-MS), SLC39A10 (Affinity Capture-MS)

ESM2 similar proteins: A0A0G2KQY6, A0A6I8PMZ8, A0JPN2, A4IGY6, A5D7L5, E9PU17, E9PX95, F1QYC4, F1S5L4, O35119, O60353, O62852, O94402, O95477, P0DX17, P41233, Q08E40, Q13433, Q15043, Q3SZN3, Q3TT99, Q4V887, Q504Y0, Q5FVQ0, Q5FWH7, Q5GJ77, Q5R9M9, Q5RAB7, Q5RCN4, Q61089, Q61586, Q6L8F3, Q6P5F6, Q6PEH9, Q6R5J1, Q6W3E5, Q75N73, Q84M24, Q8C145, Q8WMU5

Diamond homologs: A0A0G2KQY6, A0A6I8PMZ8, A4IGY6, A5D7H1, A5D7L5, A8WMY3, A8X482, L5KLU7, P0DX17, Q06916, Q15043, Q1KZG0, Q29175, Q2M1K6, Q31125, Q504Y0, Q5FVQ0, Q5FWH7, Q5R6I6, Q5RAB7, Q5RFD5, Q5TJF6, Q6L8F3, Q6MGB4, Q6P5F6, Q6PEH9, Q75N73, Q78IQ7, Q8AW42, Q8BZH0, Q91W10, Q92504, Q96H72, Q9C0K1, Q9M647, Q9PUB8, Q9ULF5, Q9UT11, Q9V3A4, Q9XTQ7

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 169 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Lysosphingolipid and LPA receptors536.6×1e-04
DAP12 signaling517.7×5e-04
Signaling by SCF-KIT511.9×2e-03
Class A/1 (Rhodopsin-like receptors)107.1×2e-04
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell75.9×4e-03
GPCR ligand binding95.5×1e-03

GO biological processes:

GO termPartnersFoldFDR
G protein-coupled receptor signaling pathway153.8×5e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

97 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance75
Likely benign9
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2414 predictions. Top by Δscore:

VariantEffectΔscore
2:195681047:TGAA:Tdonor_gain1.0000
2:195681048:GAA:Gdonor_gain1.0000
2:195681048:GAAG:Gdonor_gain1.0000
2:195681049:AA:Adonor_gain1.0000
2:195681050:AG:Adonor_loss1.0000
2:195681051:G:GGdonor_gain1.0000
2:195681052:TAAG:Tdonor_loss1.0000
2:195683697:A:AGacceptor_gain1.0000
2:195683698:G:GGacceptor_gain1.0000
2:195683698:GT:Gacceptor_gain1.0000
2:195683902:ATCAG:Adonor_loss1.0000
2:195683904:CAGGT:Cdonor_loss1.0000
2:195683905:AGGT:Adonor_loss1.0000
2:195683906:GGT:Gdonor_loss1.0000
2:195683907:GT:Gdonor_loss1.0000
2:195683908:T:Gdonor_loss1.0000
2:195706614:A:AGacceptor_gain1.0000
2:195706615:G:GGacceptor_gain1.0000
2:195706782:CCAT:Cdonor_gain1.0000
2:195706784:ATG:Adonor_loss1.0000
2:195706785:TGTA:Tdonor_loss1.0000
2:195706786:G:Cdonor_loss1.0000
2:195706786:G:GGdonor_gain1.0000
2:195706787:T:Adonor_loss1.0000
2:195708654:A:AGacceptor_gain1.0000
2:195708655:G:GTacceptor_gain1.0000
2:195708655:GTCT:Gacceptor_gain1.0000
2:195708655:GTCTC:Gacceptor_gain1.0000
2:195708841:AAGA:Adonor_gain1.0000
2:195708841:AAGAG:Adonor_loss1.0000

AlphaMissense

5619 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:195706651:A:CS418R1.000
2:195706653:C:AS418R1.000
2:195706653:C:GS418R1.000
2:195706669:G:CG424R1.000
2:195706744:G:AG449R1.000
2:195706744:G:CG449R1.000
2:195706745:G:AG449E1.000
2:195706753:A:CS452R1.000
2:195706755:T:AS452R1.000
2:195706755:T:GS452R1.000
2:195706756:G:AG453R1.000
2:195706756:G:CG453R1.000
2:195706757:G:AG453E1.000
2:195706759:G:CD454H1.000
2:195706760:A:TD454V1.000
2:195706769:T:CL457P1.000
2:195706771:C:GH458D1.000
2:195706775:T:AL459Q1.000
2:195706775:T:CL459P1.000
2:195716949:C:AA670D1.000
2:195716966:G:AG676R1.000
2:195716966:G:CG676R1.000
2:195716966:G:TG676W1.000
2:195716969:G:CD677H1.000
2:195716970:A:CD677A1.000
2:195716970:A:GD677G1.000
2:195716970:A:TD677V1.000
2:195716971:T:AD677E1.000
2:195716971:T:GD677E1.000
2:195716972:G:CG678R1.000

dbSNP variants (sampled 300 via entrez): RS1000055529 (2:195635958 A>G), RS1000056204 (2:195688254 A>C), RS1000087578 (2:195645398 T>C), RS1000143479 (2:195721701 A>C), RS1000164284 (2:195732103 T>C,G), RS1000198366 (2:195639006 A>G), RS1000270523 (2:195638742 G>A), RS1000279244 (2:195682049 C>T), RS1000324939 (2:195682065 A>T), RS1000351017 (2:195669023 C>G,T), RS1000356383 (2:195611340 A>G), RS1000383675 (2:195735219 G>C), RS1000437953 (2:195724848 G>A), RS1000463541 (2:195675538 C>G), RS1000483394 (2:195633328 G>A)

Disease associations

OMIM: gene MIM:608733 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST001531_4Temperament6.000000e-06
GCST002790_3Food allergy5.000000e-06

EFO canonical traits (2, from GWAS)

EFO IDTrait name
EFO:0004825temperament and character inventory
EFO:0007016food allergy measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: transporter — SLC39 family of metal ion transporters

CTD chemical–gene interactions

71 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
Air Pollutantsaffects cotreatment, increases abundance, increases oxidation, affects expression, decreases expression4
Cyclosporinedecreases expression4
sodium arseniteincreases abundance, decreases expression3
Benzo(a)pyreneaffects methylation, increases expression3
Estradiolaffects cotreatment, increases expression, decreases expression3
Valproic Acidaffects expression, decreases expression, decreases methylation3
Zincincreases transport, affects cotreatment, decreases expression, increases expression3
bisphenol Adecreases expression2
perfluorooctane sulfonic aciddecreases expression2
Cadmiumdecreases expression, increases response to substance, increases abundance2
Ozoneincreases abundance, affects expression, affects cotreatment, increases oxidation2
Phenylmercuric Acetateaffects cotreatment, decreases expression2
Aflatoxin B1affects expression, increases expression2
Cadmium Chloridedecreases expression, increases abundance2
p-Chloromercuribenzoic Acidaffects cotreatment, decreases expression2
Particulate Matterdecreases expression, increases abundance2
afuresertibdecreases expression1
FR900359affects phosphorylation1
ginger extractincreases abundance, decreases expression1
dicrotophosdecreases expression1
triphenyl phosphateaffects expression1
alpha-pineneaffects cotreatment, increases oxidation, increases abundance1
arseniteaffects binding, decreases reaction1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
ochratoxin Aaffects cotreatment, decreases expression1
potassium chromate(VI)decreases expression, affects cotreatment1
coumarinincreases phosphorylation1
methacrylaldehydeaffects cotreatment, increases oxidation, increases abundance1
N,N,N’,N’-tetrakis(2-pyridylmethyl)ethylenediamineaffects cotreatment, decreases expression1
beta-methylcholineaffects expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.